What's New
Media & Press Updates
In4Derm raises £1.6m pre-Series A funding to support its growing pipeline of first-in-class anti-inflammatory and orphan disease therapeutics
November 2nd 2021
In4Derm
Because Skin Matters
Our approach
Delivering first in class therapies for skin disease
We specialize in the discovery of drugs, which are safe and effective, for the treatment of skin diseases including eczema, non-melanoma skin cancers and orphan skin diseases
By discovering the next generation of therapies, we hope to greatly improve the well-being of patients with these conditions.
We would love to tell you more so please contact us with your questions.
